We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Integumen Plc | LSE:SKIN | London | Ordinary Share | GB00BMGWZY29 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 28.00 | 28.00 | 29.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSKIN
RNS Number : 1868B
Integumen PLC
19 September 2018
19 September 2018
Integumen plc
("Integumen" or "the Company")
Update : details of legal demand; finalisation of Placing and Subscription
The Company announced in its Interim Report on 29 August 2018 that it is seeking to divest itself of under-performing assets, and further that the Company had declined an offer for its skin care division received from Mr Donald Nicholson as it seriously undervalued the assets being sought for purchase, many of which were not for sale.
Subsequently, the Company has received a formal demand for payment of certain amounts due and claimed to be due to Mr. Nicholson and Mercuriali Limited, for services provided to the Company. Mercuriali is owned by Mr Nicholson and is a c11% shareholder in Integumen.
Whilst the Board acknowledges that certain of the claimed amounts are owed to Mr Nicholson and Mercurali, it notes that Mr Nicholson, on behalf of himself and Mercuriali, previously agreed that these amounts are not due to be paid before 9 July 2019.
In addition the formal notice seeks payment of debts owed by Integumen Inc, one of Integumen plc's subsidiaries, to third parties.
The Company believe these demands for immediate payment are without merit, and it will strongly contest such claims if pursued.
The Board expects to complete the final elements of the Subscription, the Placing and acquisition of a stake in Cellulac plc, as announced on 16 July 2018 (and updated on 19 July 2018 and 24 July 2018), shortly.
Hot Features
Premium
Gerard Brandon, Chief
Integumen plc Executive +44 (0) 1223 926 660
SPARK Advisory Partners
Limited Neil Baldwin/Andrew
(Nominated Adviser) Emmott +44 (0) 113 370 8974
----------------------- ---------------------
Hybridan LLP (Broker) Claire Noyce +44 (0) 20 3764 2341
----------------------- ---------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCSFMEFAFASEIU
(END) Dow Jones Newswires
September 19, 2018 02:01 ET (06:01 GMT)
1 Year Integumen Chart |
1 Month Integumen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
